Latest from @Action_Canada :
Sandeep Prasad, executive director of Action Canada for Sexual Health and Rights, said he was surprised to see New Brunswick taking a proactive approach to a publicly funded abortion pill. He said he hopes other provinces follow suit.
“New Brunswick was in the top two provinces that were the slowest to progress in terms of abortion access — P.E.I. being the other one, where we simply did not see services in the province for years,” said Prasad in a phone interview from Ottawa.
“The fact that it’s New Brunswick announcing this first, I think that’s going to add some real pressure on some of the other provinces who would say they’re a lot better at abortion access than New Brunswick.”
The Common Drug Review, which evaluates new drugs and recommends whether it should be covered by public drug plans, is currently reviewing Mifegymiso.